DNA amplification of nasopharyngeal aspirates in rats: A procedure to detect Pneumocystis carinii

Helieh S. Oz, Walter T. Hughes

Research output: Contribution to journalArticle

Abstract

The diagnosis of Pneumocystis carinii pneumonia (PCP) requires invasive methods of bronchoalveolar lavage and lung biopsy. In this study, we examined efficacy of polymerase chain reaction (PCR) compared to Giemsa and silver ammoniacal staining to detect P. carinii in easily accessible extrapulmonary sites as well as lung. Samples were collected from lung, nasal and pharyngeal aspirates, gastric contents, urine and blood from dexamethasone treated or untreated virus-free Sprague-Dawley rats. All immunosuppressed lung samples were P. carinii positive by PCR analysis and both stains. Respectively DNA fragments of P. carinii were found in 93%, of nasal and 75% of pharyngeal aspirates, and 0% of sera, urine or gastric aspirates from immunosuppressed rats. However, no P. carinii cysts or trophozoites were found in nasal and pharyngeal aspirates (extrapulmonary sites) by silver ammoniacal or Giemsa staining. In comparison, none of the specimens from immunocompetent rats were PCR positive at any sites tested including the lungs. Therefore, PCR amplification products of nasal and pharyngeal aspirates showed that immunosuppressed rats with PCP can carry P. carinii DNA fragments in their upper respiratory tracts, but immunocompetent animals without PCP, are free of the organism and this suggests an approach to be investigated in humans with PCP.

Original languageEnglish (US)
Pages (from-to)119-121
Number of pages3
JournalMicrobial Pathogenesis
Volume27
Issue number2
DOIs
StatePublished - Aug 1999
Externally publishedYes

Fingerprint

Pneumocystis carinii
Pneumocystis Pneumonia
Nose
Lung
DNA
Polymerase Chain Reaction
Urine
Trophozoites
Gastrointestinal Contents
Silver Staining
Bronchoalveolar Lavage
Respiratory System
Dexamethasone
Sprague Dawley Rats
Cysts
Stomach
Coloring Agents
Staining and Labeling
Viruses
Biopsy

Keywords

  • Nasopharyngeal aspirates
  • PCR
  • Pneumocystis carinii pneumonia
  • Rat

ASJC Scopus subject areas

  • Microbiology
  • Infectious Diseases

Cite this

DNA amplification of nasopharyngeal aspirates in rats : A procedure to detect Pneumocystis carinii. / Oz, Helieh S.; Hughes, Walter T.

In: Microbial Pathogenesis, Vol. 27, No. 2, 08.1999, p. 119-121.

Research output: Contribution to journalArticle

@article{6c167150a1204d6d8350a3bf259f3e17,
title = "DNA amplification of nasopharyngeal aspirates in rats: A procedure to detect Pneumocystis carinii",
abstract = "The diagnosis of Pneumocystis carinii pneumonia (PCP) requires invasive methods of bronchoalveolar lavage and lung biopsy. In this study, we examined efficacy of polymerase chain reaction (PCR) compared to Giemsa and silver ammoniacal staining to detect P. carinii in easily accessible extrapulmonary sites as well as lung. Samples were collected from lung, nasal and pharyngeal aspirates, gastric contents, urine and blood from dexamethasone treated or untreated virus-free Sprague-Dawley rats. All immunosuppressed lung samples were P. carinii positive by PCR analysis and both stains. Respectively DNA fragments of P. carinii were found in 93{\%}, of nasal and 75{\%} of pharyngeal aspirates, and 0{\%} of sera, urine or gastric aspirates from immunosuppressed rats. However, no P. carinii cysts or trophozoites were found in nasal and pharyngeal aspirates (extrapulmonary sites) by silver ammoniacal or Giemsa staining. In comparison, none of the specimens from immunocompetent rats were PCR positive at any sites tested including the lungs. Therefore, PCR amplification products of nasal and pharyngeal aspirates showed that immunosuppressed rats with PCP can carry P. carinii DNA fragments in their upper respiratory tracts, but immunocompetent animals without PCP, are free of the organism and this suggests an approach to be investigated in humans with PCP.",
keywords = "Nasopharyngeal aspirates, PCR, Pneumocystis carinii pneumonia, Rat",
author = "Oz, {Helieh S.} and Hughes, {Walter T.}",
year = "1999",
month = "8",
doi = "10.1006/mpat.1999.0292",
language = "English (US)",
volume = "27",
pages = "119--121",
journal = "Microbial Pathogenesis",
issn = "0882-4010",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - DNA amplification of nasopharyngeal aspirates in rats

T2 - A procedure to detect Pneumocystis carinii

AU - Oz, Helieh S.

AU - Hughes, Walter T.

PY - 1999/8

Y1 - 1999/8

N2 - The diagnosis of Pneumocystis carinii pneumonia (PCP) requires invasive methods of bronchoalveolar lavage and lung biopsy. In this study, we examined efficacy of polymerase chain reaction (PCR) compared to Giemsa and silver ammoniacal staining to detect P. carinii in easily accessible extrapulmonary sites as well as lung. Samples were collected from lung, nasal and pharyngeal aspirates, gastric contents, urine and blood from dexamethasone treated or untreated virus-free Sprague-Dawley rats. All immunosuppressed lung samples were P. carinii positive by PCR analysis and both stains. Respectively DNA fragments of P. carinii were found in 93%, of nasal and 75% of pharyngeal aspirates, and 0% of sera, urine or gastric aspirates from immunosuppressed rats. However, no P. carinii cysts or trophozoites were found in nasal and pharyngeal aspirates (extrapulmonary sites) by silver ammoniacal or Giemsa staining. In comparison, none of the specimens from immunocompetent rats were PCR positive at any sites tested including the lungs. Therefore, PCR amplification products of nasal and pharyngeal aspirates showed that immunosuppressed rats with PCP can carry P. carinii DNA fragments in their upper respiratory tracts, but immunocompetent animals without PCP, are free of the organism and this suggests an approach to be investigated in humans with PCP.

AB - The diagnosis of Pneumocystis carinii pneumonia (PCP) requires invasive methods of bronchoalveolar lavage and lung biopsy. In this study, we examined efficacy of polymerase chain reaction (PCR) compared to Giemsa and silver ammoniacal staining to detect P. carinii in easily accessible extrapulmonary sites as well as lung. Samples were collected from lung, nasal and pharyngeal aspirates, gastric contents, urine and blood from dexamethasone treated or untreated virus-free Sprague-Dawley rats. All immunosuppressed lung samples were P. carinii positive by PCR analysis and both stains. Respectively DNA fragments of P. carinii were found in 93%, of nasal and 75% of pharyngeal aspirates, and 0% of sera, urine or gastric aspirates from immunosuppressed rats. However, no P. carinii cysts or trophozoites were found in nasal and pharyngeal aspirates (extrapulmonary sites) by silver ammoniacal or Giemsa staining. In comparison, none of the specimens from immunocompetent rats were PCR positive at any sites tested including the lungs. Therefore, PCR amplification products of nasal and pharyngeal aspirates showed that immunosuppressed rats with PCP can carry P. carinii DNA fragments in their upper respiratory tracts, but immunocompetent animals without PCP, are free of the organism and this suggests an approach to be investigated in humans with PCP.

KW - Nasopharyngeal aspirates

KW - PCR

KW - Pneumocystis carinii pneumonia

KW - Rat

UR - http://www.scopus.com/inward/record.url?scp=0032764798&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032764798&partnerID=8YFLogxK

U2 - 10.1006/mpat.1999.0292

DO - 10.1006/mpat.1999.0292

M3 - Article

C2 - 10458922

AN - SCOPUS:0032764798

VL - 27

SP - 119

EP - 121

JO - Microbial Pathogenesis

JF - Microbial Pathogenesis

SN - 0882-4010

IS - 2

ER -